Innoviva (FRA:HVE) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:HVE Innoviva Inc FRA:HVE
86 GF Score
Price €18.20
GF Value €17.79
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Innoviva Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:HVE
86GF Score
Innoviva Inc FRA:HVE
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Innoviva (FRA:HVE) Overvalued in 2026?

Based on GuruFocus' analysis, Innoviva stock appears to be overvalued. The current stock price of €18.20 is trading 2.3% above its estimated GF Value™ of €17.79. GuruFocus considers Innoviva to be Fairly Valued.

Key valuation signals for FRA:HVE:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €17.79 vs. price of €18.20 (2.3% above fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the FRA:HVE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Innoviva Business Description

Other Exchanges INVA:USA
Address 1350 Old Bayshore Highway, Suite 400, Burlingame, CA, USA, 94010
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
86GF Score

Get the complete analysis for FRA:HVE

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.20
Price
€17.79
GF Value